Boston Herald

US, UK, CANADA ACCUSE KREMLIN OF VIRUS HACK

Experts: Attempt to steal vaccine secrets part of Russia’s ‘playbook’

- by Rick Sobey

Russian hackers accused of trying to steal coronaviru­s vaccine research from the U.S. is straight out of the Kremlin’s cyber playbook and shows how they’re “willing to hack just about anything,” especially during a global pandemic, security experts told the Herald.

It doesn’t appear that the alleged hacking set back vaccine developmen­t in the U.S., the experts added.

The U.S., U.K. and Canada on Thursday revealed that Russian cyber actors are targeting organizati­ons involved in the coronaviru­s vaccine developmen­t.

“It’s not surprising at all,” said Jason Blazakis, director of the Center on Terrorism, Extremism, and Counterter­rorism at the Middlebury Institute of Internatio­nal Studies at Monterey. “This has been part of the Russians’ overarchin­g playbook, to use their cyber capabiliti­es to steal informatio­n and drug-related secrets.

“Russians wanting to steal informatio­n about the vaccine during a time of great instabilit­y is not surprising at all,” he added.

The three Western nations in a joint press release detailed activities of the cyber threat group known as APT29, which has exploited organizati­ons around the world. APT29, also named “the Dukes” or “Cozy Bear” almost certainly operates as part of Russian intelligen­ce services, officials said.

“APT29’s campaign of malicious activity is ongoing, predominan­tly against government, diplomatic, think-tank, healthcare and energy targets to steal valuable intellectu­al property,” the joint advisory reads.

British Foreign Secretary Dominic Raab said in a statement, “It is completely unacceptab­le that the Russian Intelligen­ce Services are targeting those working to combat the coronaviru­s pandemic. While others pursue their selfish interests with reckless behaviour, the U.K. and its allies are getting on with the hard work of finding a vaccine and protecting global health.”

The group APT29 uses a variety of tools and techniques, including spearphish­ing and custom malware known as “WellMess” and “WellMail,” according to the advisory.

“We condemn these despicable attacks against those doing vital work to combat the coronaviru­s pandemic,” Paul Chichester, the U.K.’s National Cyber Security Centre director of operations, said in a statement. “Working with our allies, the NCSC is committed to protecting our most critical assets and our top priority at this time is to protect the health sector.”

The Russian Embassy in the U.S. denied the allegation­s, writing on Twitter, “Accusation­s against @Russia of hacker attacks on Western pharmaceut­ical companies are an attempt to tarnish the Russian #Covid19 vaccine, which may become the world’s first.”

These recent allegation­s are further evidence that Russia is “a hacking power and willing to hack almost anything,” said Chris Miller, co-director of the Russia and Eurasia Program at The Fletcher School at Tufts University.

People might be concerned about this disrupting U.S. activities to develop a vaccine, but the hacking didn’t appear to delay vaccine efforts, he noted.

The three nations — U.S., U.K. and Canada — coming together on this statement is part of the allies’ strategy to “maim and shame Russia for its hacking efforts,” Miller said.

“A lot of people in government think that maiming and shaming will deter Russia,” he said. “This coordinate­d effort is to design credibilit­y for the statement, and show that this is something to be taken seriously.”

 ?? GETTY IMAGES ?? ‘NOT SURPRISING’: Leisure boats float on the Moskva River in front of the Kremlin on Thursday. Russian hackers tried to steal vaccine secrets from the U.S., U.K. and Canada, experts say.
GETTY IMAGES ‘NOT SURPRISING’: Leisure boats float on the Moskva River in front of the Kremlin on Thursday. Russian hackers tried to steal vaccine secrets from the U.S., U.K. and Canada, experts say.
 ??  ??
 ?? AP FILE PHOTOS ?? FIRST STAGE: A subject receives a shot for a clinical trial of a potential vaccine by Moderna for COVID-19.
AP FILE PHOTOS FIRST STAGE: A subject receives a shot for a clinical trial of a potential vaccine by Moderna for COVID-19.

Newspapers in English

Newspapers from United States